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Background: Methylsulfonylmethane (MSM) has been reported to provide anti-inflammatory and antioxidant
effects in both animal and man. Strenuous resistance exercise has the potential to induce both inflammation and
oxidative stress. Using a pilot (proof of concept) study design, we determined the influence of MSM on markers of
exercise recovery and performance in healthy men.
Methods: Eight, healthy men (27.1 ± 6.9 yrs old) who were considered to be moderately exercise-trained (exercising
<150 minutes per week) were randomly assigned to ingest MSM at either 1.5 grams per day or 3.0 grams per day
for 30 days (28 days before and 2 days following exercise). Before and after the 28 day intervention period, subjects
performed 18 sets of knee extension exercise in an attempt to induce muscle damage (and to be used partly as a
measure of exercise performance). Sets 1–15 were performed at a predetermined weight for 10 repetitions each,
while sets 16–18 were performed to muscular failure. Muscle soreness (using a 5-point Likert scale), fatigue (using
the fatigue-inertia subset of the Profile of Mood States), blood antioxidant status (glutathione and Trolox Equivalent
Antioxidant Capacity [TEAC]), and blood homocysteine were measured before and after exercise, pre and post
intervention. Exercise performance (total work performed during sets 16–18 of knee extension testing) was also
measured pre and post intervention.
Results: Muscle soreness increased following exercise and a trend was noted for a reduction in muscle soreness
with 3.0 grams versus 1.5 grams of MSM (p = 0.080), with a 1.0 point difference between dosages. Fatigue was
slightly reduced with MSM (p = 0.073 with 3.0 grams; p = 0.087 for both dosages combined). TEAC increased
significantly following exercise with 3.0 grams of MSM (p = 0.035), while homocysteine decreased following exercise
for both dosages combined (p = 0.007). No significant effects were noted for glutathione or total work performed
during knee extension testing (p > 0.05).
Conclusion: MSM, especially when provided at 3.0 grams per day, may favorably influence selected markers of
exercise recovery. More work is needed to extend these findings, in particular using a larger sample of subjects and
the inclusion of additional markers of exercise recovery and performance.
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Methylsulfonylmethane (MSM) is a naturally occurring
nutrient composed of sulfur, oxygen and methyl groups
[1]. In the presence of ozone and high-energy ultraviolet
light, MSM (along with dimethyl sulfoxide [DMSO]) is
formed from dimethyl sulfide, taken up into atmosphere,
returned to the earth in rainfall, and taken into the root
systems of plants. As such, MSM can be found in small
quantities in a variety of foods [2], such as milk, fruits
and vegetables (e.g., tomatoes, corn), coffee, and tea.
While multiple health-related benefits are attributed to
sulfur in general [3], and to MSM specifically—ranging
from improved physical function [4] to a potential
reduction in certain cancer risk [5], the proposed
mechanisms of action for MSM appear related to both
anti-inflammatory [6] and anti-oxidative activity [7].
MSM may inhibit the translocation of the p65 subunit
of nuclear factor (NF)-kß to the nucleus [6], thus min-
imizing downstream events associated with local and
systemic inflammation. Indeed, supplementation with
MSM may minimize the expression of pro-inflammatory
cytokines [8]. MSM has been reported to increase anti-
oxidant defense (glutathione) [9], as well as decrease the
actual production of reactive oxygen species (ROS) [7].
As with pro-inflammatory biomarkers, supplementation
with MSM has resulted in a lowering of multiple oxida-
tive stress biomarkers [10,11].
Collectively, these findings suggest that MSM might
favorably influence exercise recovery, as both inflamma-
tion and oxidative stress may be involved in the etiology
of exercise-induced muscle damage and associated
symptoms [12]. Considering this and the excellent safety
profile of MSM, we used a pilot (proof of concept) study
design to determine the influence of MSM on markers
of exercise recovery and performance in healthy men. At
the time of study conception, we were unaware of any
published trials focused on the use of MSM as a poten-
tial exercise recovery agent. We hypothesized that MSM
would favorably influence our outcome measures (e.g.,
reduce muscle soreness, reduce muscle fatigue, increase
antioxidant capacity), providing justification for further




Eight healthy men (27.1 ± 6.9 yrs old) who were consid-
ered to be moderately exercise-trained (exercising
<150 minutes per week) were recruited to participate in
an open label (unblinded) pilot study. Eligibility was
determined by completion of a health history form
(Physical Activity Readiness Questionnaire [PAR-Q]) and
physical examination. All subjects had experience per-
forming resistance exercise, to ensure that the exerciseprotocol they were exposed to in the present design did
not present a novel challenge. All subjects were
instructed to maintain their pre-study exercise program
throughout the course of the study, with the exception
of refraining from exercise during the 24 hours prior to
each test day and during the 48 hours following each
test day. Subjects were nonsmokers, did not report any
history of cardiovascular, metabolic, neurological, mus-
cular, or orthopedic disorders that may have impacted
their ability to participate in the study, and did not start
the use of any new nutritional supplement or medication
over the course of the study. However, subjects were
allowed to continue using nutritional supplements and
medications they had been using prior to beginning the
study (e.g., multivitamins, acetaminophen), with the ex-
ception of the 24 hours prior to each test day and the
48 hours following each test day. Prior to participation,
each subject was informed of all procedures, potential
risks, and benefits associated with the study through
both verbal and written form in accordance with the
approved procedures of the Aspire Institutional Review
Board for Human Subjects Research (La Mesa, CA; ap-
proval date of March 1, 2011). Subjects signed an
informed consent form prior to being admitted into the
study.
At the screening visits, the subjects’ height via stadi-
ometer (Holtain Limited; Britain) and body mass via
digital scale (Detecto; Webb City, MO) were measured
and recorded. Body mass was obtained with subjects
wearing only a gown and underwear. Heart rate and blood
pressure (using subjects’ left arm) were recorded following
a minimum of five minutes of quiet rest, while seated in a
chair. A 12-lead electrocardiogram was obtained and
analyzed for normality, to ensure subject suitability for
participation. A blood sample was collected from subjects
for routine assessment of clinical chemistry parameters
(e.g., metabolic panel and complete blood count).
Please see Table 1 for subject descriptive characteristics
and Table 2 for blood parameters. During the initial la-
boratory visit, a 1-repetition maximum (1-RM) test for
the knee extension exercise was also conducted using
standard procedures, allowing 2–4 minutes between
successive attempts. In addition, a familiarization trial
of the exercise protocol was performed (one set of 10
repetitions performed at 30%, 45%, 60% and 70% 1-RM
for a total of 40 repetitions).
Supplementation
Subjects were randomly assigned (via a Block-2
randomization scheme) to ingest MSM at either 1.5
grams per day (n = 4) or 3.0 grams per day (n = 4) for
28 days prior to performing the exercise test, in addition
to the two days following the exercise test (i.e., the re-
covery period). Subjects were instructed to begin the
Table 1 Characteristics of 8 healthy men assigned to MSM
Variable 1.5 g/day (n = 4) 3.0 g/day (n = 4) All Subjects p-value
Age (yrs) 31.5 ± 5.9 22.8 ± 4.9 27.1 ± 6.9 0.063
33.5 (23.0 – 36.0) 21 (19.0 – 30.0) 26.5 (19.0 – 36.0)
Height (cm) 175.5 ± 4.4 177.0 ± 2.2 176.3 ± 3.3 0.565
175.0 (171.0 – 181.0) 176.5 (175.0 – 180.0) 176.5 (171.0 – 181.0)
Weight (kg) 75.0 ± 5.3 75.0 ± 3.9 75.0 ± 4.3 0.988
75.7 (68.0 – 80.8) 73.3 (72.4 – 80.8) 74.4 (68.0 – 80.8)
BMI (kgm-2) 24.4 ± 1.6 23.9 ± 1.5 24.2 ± 1.4 0.703
24.5 (22.8 – 25.8) 23.9 (22.3 – 25.8) 23.9 (22.3 – 25.8)
SBP (mm Hg) 118.0 ± 2.9 110.0 ± 14.9 114.0 ± 10.8 0.772
118.5 (114.0 – 121.0) 115.0 (89.0 – 121.0) 118.5 (89.0 – 121.0)
DBP (mm Hg) 75.5 ± 2.1 73.0 ± 8.2 74.3 ± 5.7 0.576
75.5 (73.0 – 78.0) 74.5 (62.0 – 81.0) 75.5 (62.0 – 81.0)
HR (bpm) 58.3 ± 4.9 66.3 ± 6.7 62.3 ± 6.9 0.103
58.0 (54.0 – 63.0) 64 (61.0 – 76.0) 62.5 (54.0 – 76.0)
QTcB (msec) 383.5 ± 7.6 376.8 ± 15.6 380.1 ± 11.9 0.470
383.7 (374.0 – 392.5) 374.4 (360.3 – 398.0) 379.3 (360.3 – 398.0)
Data are mean ± SD (top row); median and (range) provided in bottom row.
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test session, once data collection for the recovery period
was completed. Please see Table 3 for a depiction of the
study variables and timeline for measurement. TheTable 2 Metabolic panel and blood counts of 8 healthy men a
Variable 1.5 g/day (n= 4) 3.0
Glucose (mgdL-1) 85.3 ± 2.6
85.0 (83.0 – 88.0) 94.5
BUN (mgdL-1) 15.8 ± 4.8
16.0 (10.0 – 21.0) 13.5
Creatinine (mgdL-1) 1.0 ± 0.1
1.0 (0.8 – 1.0) 0.9
AP (UnitsL-1) 73.5 ± 25.0 8
71.0 (47.0 – 105.0) 78.0
AST (UnitsL-1) 19.8 ± 4.9
19.5 (14.0 – 26.0) 16.5
ALT (UnitsL-1) 21.3 ± 10.9
17.0 (14.0 – 37.0) 21.0
WBC (thousandμL-1) 5.60 ± 1.49 7
5.9 (3.6 – 7.1) 7.1
RBC (millionμL-1) 5.2 ± 0.3
5.1 (4.9 – 5.7) 5.5
Hemoglobin (gdL-1) 14.9 ± 0.4
14.9 (14.5 – 15.3) 15.8
Hematocrit (%) 48.2 ± 2.0
48.0 (46.4 – 50.3) 50.2
Data are mean ± SD (top row); median and (range) provided in bottom row.MSM (OptiMSMW) was provided by Bergstrom Nutri-
tion (Vancouver, WA) and was produced under Good
Manufacturing Practice. Capsules contained 750 mg of
MSM and subjects ingested two or four capsules dailyssigned to MSM
g/day (n= 4) All Subjects p-value
96.3 ± 7.1 90.8 ± 7.7 0.028
(90.0 – 106.0) 89.0 (83.0 – 106.0)
12.8 ± 2.6 14.3 ± 3.9 0.314
(9.0 – 15.0) 14.0 (9.0 – 21.0)
0.9 ± 0.1 1.0 ± 0.1 0.561
(0.8 – 1.0) 1.0 (0.8 – 1.0)
5.0 ± 23.4 79.3 ± 23.2 0.527
(66.0 – 118.0) 75.5 (47.0 – 118.0)
16.0 ± 2.4 17.9 ± 4.1 0.222
(13.0 – 18.0) 18.0 (13.0 – 26.0)
20.0 ± 6.7 20.6 ± 8.4 0.851
(11.0 – 27.0) 20.0 (11.0 – 37.0)
.10 ± 1.79 6.35 ± 1.72 0.245
(5.0 – 9.3) 6.4 (3.6 – 9.3)
5.4 ± 0.2 5.3 ± 0.3 0.255
(5.2 – 5.6) 5.3 (4.9 – 5.7)
15.7 ± 0.9 15.3 ± 0.8 0.172
(14.6 – 16.6) 15.2 (14.5 – 16.6)
49.9 ± 2.3 49.0 ± 2.2 0.313
(47.2 – 51.8) 49.1 (46.4 – 51.8)
Table 3 Study timeline and outcome measures
Time ! Pre/Post MSM* Pre/Post MSM Pre/Post MSM Pre/Post MSM
Variable # Pre exercise Immediately post-exercise 2 hours Post-exercise 48 hours Post-exercise
Muscle Soreness X X X
Fatigue Questionnaire X X X
Exercise Performance X
Blood Homocysteine X X X
Blood TEAC X X X
Blood Glutathione X X X
* Pre/Post MSM refers to Pre intervention (prior to use of MSM; test visit 1) and Post Intervention (after supplementation with MSM; test visit 2).
TEAC: Trolox Equivalent Antioxidant Capacity.
Kalman et al. Journal of the International Society of Sports Nutrition 2012, 9:46 Page 4 of 11
http://www.jissn.com/content/9/1/46(divided into a morning and night dosage) in order to
provide the dosage of 1.5 or 3.0 grams, respectively. No
blood measurement of MSM before and after supple-
mentation was included in this study. Hence, capsule
counts upon bottle return allowed for the sole calcula-
tion of compliance to treatment.Physical activity and dietary intake
Subjects were instructed to maintain their normal phys-
ical activity throughout the study period, with the excep-
tion of refraining from strenuous physical activity during
the 24 hours prior to each test day and during the
48 hours following each test day. They were also given
specific instructions regarding abstinence from alcohol,
medication, and dietary supplement consumption during
the 24 hours immediately before the test days and dur-
ing the 48 hours following each test day. Dietary intake
was to be maintained as usual through the study period,
with the exception of reporting to the lab in a fasted
state on each of the two test days (no food, caffeine, or
calorie containing beverages allowed after midnight). No
food records were maintained in this study, which may
be considered a limitation of this work.Exercise test days
On each of the two exercise test days, subjects reported
to the lab in the morning following an overnight fast.
However, subjects were instructed to consume water lib-
erally up to the time they reported to the lab for testing.
Adherence to study instructions was confirmed with all
subjects on each day of testing by use of a dichotomous
questionnaire. Specifically, on the day of testing, we used
an in-lab questionnaire asking subjects if they consumed
any food since midnight the night before, or any alcohol,
caffeine, or nutritional supplements during the prior
24 hours. We also used phone questionnaires during the
study period asking subjects if they exercised since the
last study visit, used any vitamin and/or mineral supple-
ments since the last study visit, or taken acetaminophen
since the last study visit.For testing days, the time of day for each subject was
matched for the subsequent test day. Following all base-
line measurements and approximately 45 minutes prior
to the start of the knee extension exercise protocol, sub-
jects were provided with a standardized breakfast con-
sisting of a bagel, one tablespoon of low fat cream
cheese, 8 ounces of orange juice, and water ad libitum.
On the test days, subjects took their assigned MSM dose
immediately prior to the standardized breakfast.
For the exercise test, subjects performed a total of 18
sets of knee extension exercise using a plate-loaded
machine (Key Fitness Products, LP; Garland, TX). Sets
1–15 were performed at a predetermined weight for
10 repetitions each, while sets 16–18 were performed
to muscular failure. Specifically, subjects performed 5
sets of 10 repetitions at 30% 1-RM for a total of 50
repetitions, followed by a 3 minute rest. Subjects then
performed 5 sets of 10 repetitions at 45% 1-RM for a
total of 50 repetitions, followed by a 3 minute rest.
Subjects then performed 5 sets of 10 repetitions at 60%
1-RM for a total of 50 repetitions, followed by a 20 mi-
nute rest (to allow muscle recovery and re-hydration as
needed—water allowed ad libitum).
Following these initial 15 sets in which the repetition
number was standardized, subjects performed 3 sets of
repetitions to failure at 70% 1-RM, with 3 minutes of
rest between each set. The total number of repetitions
performed was counted and used as an indicator of total
work performed (reps x load = volume load). Before and
following the completion of the exercise test, outcome
measures were assessed as indicated below. It should be
noted that the exercise protocol used in this study is
similar in volume as other exercise protocols used to in-
duce muscle fatigue. However, to our knowledge, this
exact protocol has not been used in other published
work focused on muscle injury and oxidative stress, but
was developed based on general resistance exercise
guidelines presented in published form [13]. In hind-
sight, although the protocol was of similar volume as
those used in past studies of muscle injury and oxidative
stress, the overall intensity of work may not have been
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oxidative stress, as the ideal protocol may have included
not only high volume exercise but also high force exer-
cise (i.e., pure eccentric muscle actions), which are
known to induce significant muscle trauma [14].
Outcome measures
All outcome measures were determined both pre and
post intervention (i.e., before and after intake of MSM).
As described in past research [15,16], muscle soreness
was determined using a visual analog scale: In this study
we used a 5-point Likert scale (0 = no soreness at all;
4 = very sore). The muscle soreness questionnaire was
administered before exercise and 2 and 48 hours follow-
ing the knee extension protocol with subjects reporting
the level of soreness in their legs (quadriceps) “right
now.” In addition to muscle soreness, fatigue was deter-
mined using a distinct questionnaire—the fatigue-inertia
subset of the Profile of Mood States [17,18], which
includes a 5-point Likert scale (0 = not at all, 1 = a little,
2 =moderately, 3 = quite a bit, 4 = extremely). The fatigue
questionnaire was also administered before exercise and
2 and 48 hours post-exercise with subjects reporting
their level of fatigue “right now.” Although some overlap
may be present in individuals’ view and rating of sore-
ness and fatigue, our questionnaires were distinct and
clearly represented either soreness or fatigue, both of
which were rated by subjects. Exercise performance dur-
ing the final three sets of knee extension was determined
based on total volume load (reps x load).
Heart rate and blood pressure were measured, and
venous blood was collected from subjects before exer-
cise, immediately post-exercise, and two hours post-
exercise. Blood from tubes containing EDTA was used
for total (TGSH) and oxidized (GSSG) glutathione
analysis. Specifically, whole blood was immediately
deproteinated by mixing with fresh, ice cold 5% meta-
phosphoric acid. The mixture was vortexed and then
centrifuged at 10,000 g for 5 minutes. The supernatant
was removed and immediately stored at −70°C. The
remaining whole blood from EDTA tubes was then
centrifuged at 1500 g at 4°C for 15 min to obtain
plasma. Collection tubes containing no additive were
allowed to clot at room temperature for 30 minutes
and then centrifuged at 1500 g at 4°C for 15 min to
obtain serum. Blood aliquots were stored at −70°C
until assayed, except for homocysteine which was ana-
lyzed in fresh plasma using a competitive immunoassay
format (Tri-State Clinical Laboratory Services, LLC,
Cincinnati, OH).
Antioxidant capacity was analyzed in serum using the
Trolox-equivalent antioxidant capacity (TEAC) assay
using procedures outlined by the reagent provider
(Sigma Chemical, St. Louis, MO). The coefficient ofvariation (CV) was 5.2%. For the analysis of glutathione,
whole blood was first deproteinated using 5% metaphos-
phoric acid, as indicated above. The supernatant was
then used to separately assay for TGSH and GSSG, and
reduced glutathione (GSH) was calculated mathematic-
ally. For analysis of GSSG, supernatants were first neu-
tralized with NaOH, and then 4-vinylpyridine was mixed
with the supernatant and incubated at room temperature
for one hour in order to derivatize GSH. Assays for
glutathione were performed using commercially available
reagents (Northwest Life Science Specialties, Vancouver,
WA). The CV for TGSH and GSSG was 3.2% and 4.9%,
respectively.
Statistical analysis
This was a small exploratory pilot/proof of concept
study, and it was not expected that significant changes
over time, or significant differences between treatment
groups, would be observed unless the differences were
very large. Therefore the efficacy analysis described
below should be considered only a formality; the main
purpose of this study was to generate a general sense of
the response of subjects to the two doses of MSM and
to obtain estimates of endpoint variability and other
parameters that could be used to inform the design of a
larger, more definitive study, if one were to be carried
out. The acute changes over the course of the testing
visit, and the long-term changes over the course of a
one-month MSM administration period, were tested for
significance within each group, and between the two
groups. Each outcome measure was tested using an ana-
lysis of covariance (ANCOVA), with the value of the
variable at the end of the study being the dependent
variable, the dose being the main factor, and the value of
the variable at baseline being the covariate. The coeffi-
cient of the product (relative to dose) and its standard
error of estimate were calculated from the ANCOVA.
Significant product efficacy was inferred if this coeffi-
cient was significantly different from zero. Analyses were
performed using “R” statistical software (version 2.13.1;
R Foundation for Statistical Computing). Statistical sig-
nificance was set at p ≤ 0.05. The data are presented
within the text, Tables, and Figures as mean ± SD.
Results
Overview and adverse effects
All subjects successfully completed all aspects of this
study. Compliance to capsule intake was 99.9 ± 7.6, con-
sidering all subjects. No serious adverse events were
observed during this study. However, one subject in the
1.5 grams/day MSM group reported mild nausea during
his last visit. Heart rate and blood pressure responded as
expected to acute exercise (these variables increased
slightly and returned to baseline rapidly) and were not
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(p > 0.05).
Recovery and performance data
Regarding muscle soreness, the 1.5 grams/day group
experienced a 0.5 point greater reduction in muscle
soreness during the post intervention visit as compared
to pre intervention, and the 3.0 grams/day group experi-
enced a 1.5 point greater reduction in soreness during
the post intervention visit as compared to pre interven-
tion. This 1.0 point difference in baseline-adjusted muscle
soreness from two hours post-exercise to 48 hours post-
exercise approached statistical significance (p= 0.080),
suggesting a dose-related improvement. The Cohen's D
value for the outcome of muscle soreness was 0.28 and
the Pearson's r value (effect size) was 0.14. Muscle sore-












































































Figure 1 Muscle soreness of 8 healthy men assigned to MSM. Blue Op
presented as change from baseline (Δ from BL) on y-axis; Visit 2 is pre inte
(following MSM supplementation); Visit 1 included the screening visit. Note
and without MSM at the two hour post-exercise time (p= 0.021 and p=0.00
greater reduction in muscle soreness during Visit 3 (post intervention) as co
experienced a 1.5 point greater reduction in soreness during Visit 3 as com
soreness from two hours post-exercise to 48 hours post-exercise approache
improvement.Regarding fatigue, all subjects experienced an increase
in fatigue that trended towards significance two hours
post-exercise at the pre intervention visit (p = 0.084),
whereas there was no trend at the post intervention visit
(p = 0.181). At the pre intervention visit, subjects’ fatigue
scores increased between two and 48 hours post-exercise,
but not significantly (p = 0.470), whereas post interven-
tion, subjects fatigue scores decreased between two
and 48 hours post-exercise, but not significantly
(p = 0.336). The difference in these changes between
pre and post intervention trended toward statistical
significance (for the 3.0 grams/day group [p = 0.073]
and for all subjects [p = 0.087]). Fatigue data are pre-
sented in Figure 2.
There were no differences in the total work performed
by subjects during the pre intervention (7,901± 3,226 kg)





















































en Circle = 1.5 grams/day; Red Filled Circle = 3.0 grams/day. Data are
rvention (prior to MSM supplementation), Visit 3 is post intervention
: There were statistically significant increases in muscle soreness with
7, respectively); The 1.5 grams/day group experienced a 0.5 point
mpared to Visit 2 (pre intervention), and the 3.0 grams/day group
pared to Visit 2. This 1.0 point difference in baseline-adjusted muscle







Fatigue / Inertia Changes
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Figure 2 Fatigue of 8 healthy men assigned to MSM. Blue Open Circle = 1.5 grams/day; Red Filled Circle = 3.0 grams/day. Data are presented
as change from baseline (Δ from BL) on y-axis; Visit 2 is pre intervention (prior to MSM supplementation), Visit 3 is post intervention (following
MSM supplementation); Visit 1 included the screening visit. Note: All subjects experienced an increase in fatigue that trended towards significance
two hours post-exercise at Visit 2 (pre intervention; p=0.084), whereas there was no trend at Visit 3 (post intervention; p=0.181); At Visit 2,
subjects’ fatigue scores increased between two and 48 hours post-exercise, but not significantly (p=0.47), whereas at Visit 3, subjects fatigue
scores decreased between two and 48 hours post-exercise, but not significantly (p=0.336); the difference in these changes between Visits 2 and 3
trended toward statistical significance (for the 3.0 grams/day group [p=0.073] and for all subjects [p=0.087]).
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noted when looking at the 1.5 gram (pre: 7,161 ± 2,511 kg;
post: 6,644± 1,371 kg) and 3.0 gram (pre: 8,642 ± 4,064 kg;
post: 7,155 ± 2,748 kg) groups independently (p> 0.05).
Regarding homocysteine, during the pre intervention
visit, levels were either unchanged or increased slightly
immediately post-exercise. Post intervention, homocyst-
eine levels decreased significantly in all subjects post-
exercise (p = 0.007) and trended towards significance in
the 3.0 grams/day group (p = 0.056). Homocysteine data
are presented in Figure 3.
Regarding antioxidant capacity as measured by TEAC,
there was a statistically significant increase immediately
post-exercise for the 3.0 grams/day group (p = 0.035) at
the post intervention test visit. TEAC data are presented
in Figure 4. Glutathione status (total, oxidized, and
reduced) was unaffected by exercise or MSM supple-
mentation (p > 0.05; data not shown).Discussion
Findings from the present investigation indicate that
MSM supplementation in healthy, moderately exercise-
trained men may favorably influence selected markers of
exercise recovery. This effect appeared to be greater with
a daily dosage of 3.0 grams of MSM than a daily dosage
of 1.5 grams. Although this study included a very small
sample of subjects, which makes it difficult to confi-
dently discuss the overall meaning of our findings, our
data provide initial evidence that MSM may have effi-
cacy in regards to influencing certain markers of exercise
recovery. Further studies are needed, inclusive of a larger
sample size (~15-20 subjects per group, if not larger), a
placebo control group, and additional markers of exer-
cise recovery and performance. In such future studies,
analysis of blood MSM concentrations pre and post
intervention, as opposed to simple capsule counts as


















































































































Figure 3 Blood homocysteine of 8 healthy men assigned to MSM. Blue Open Circle = 1.5 grams/day; Red Filled Circle = 3.0 grams/day. Data
are presented as change from baseline (Δ from BL) on y-axis; Visit 2 is pre intervention (prior to MSM supplementation), Visit 3 is post
intervention (following MSM supplementation); Visit 1 included the screening visit. Note: At Visit 2 (pre intervention), homocysteine levels were
either unchanged or increased slightly immediately post-exercise, whereas at Visit 3 (post intervention), homocysteine levels decreased
significantly in all subjects post-exercise (p= 0.007) and trended towards significance in the 3.0 grams/day group (p=0.056).
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vide information related to supplement absorption, etc.).
This is the first trial to note an impact of MSM on
blood TEAC, suggesting increased antioxidant activity.
This marker, like other “global” markers of antioxidant
status (e.g., ORAC, FRAP, TRAP) provides a general
measure of the sum total of antioxidants within blood
and other tissues [19]. While the observed increase in
TEAC may indeed have relevance, future studies focused
on MSM should ideally include additional markers of
antioxidant activity, as well as markers of oxidative
stress.
While TEAC was noted to be higher post-exercise
with MSM, we did not observe the same finding for
blood glutathione, which appeared unaffected by exer-
cise or supplementation with MSM. Our results for
glutathione oppose those of DiSilvestro et al. who noted
an increase of 78% in liver glutathione when studying
male mice ingesting MSM in drinking water for 5 weeks[9]. The present study, however, was quite different in
design. For example, it involved human intake of MSM,
glutathione measured in whole blood, and the inclusion
of a physical stressor (i.e., 18 sets of knee extension exer-
cise). These differences may be responsible for the dis-
crepancies in findings.
As we believe that TEAC does in fact represent an
increase in antioxidant defense (independent of gluta-
thione), it is possible that this increase may have atte-
nuated the commonly observed rise in ROS during
and following exercise [20], resulting in attenuation of
exercise-induced oxidative stress. While oxidative stress
biomarkers were not included in the present design,
extant literature indicates a potential for this effect.
For example, we know of at least one animal study
[11] and one human study [10] that has focused on
the role of MSM to attenuate exercise-induced oxida-
tive stress. Marañon and colleagues studied competitive
































































































Figure 4 Blood TEAC of 8 healthy men assigned to MSM. Blue Open Circle = 1.5 grams/day; Red Filled Circle = 3.0 grams/day. Data are
presented as change from baseline (Δ from BL) on y-axis; Visit 2 is pre intervention (prior to MSM supplementation), Visit 3 is post intervention
(following MSM supplementation); Visit 1 included the screening visit. Note: There was a statistically significant increase in TEAC immediately
post-exercise at Visit 3 (post intervention) for the 3.0 grams/day group (p=0.035). TEAC: Trolox Equivalent Antioxidant Capacity.
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vitamin C diet (8 mg/kg MSM+5 mg/kg vitamin C)
for a period leading up to competition [11]. Blood
was collected before and within 15 minutes following
competition and analyzed for a variety of oxidative stress
markers. The competitive exercise resulted in noted
increases in lipid peroxidation, nitric oxide metabolites,
and carbon monoxide, with decreases in reduced gluta-
thione and antioxidant enzyme activity. Supplementation
with MSM significantly attenuated the observed changes
due to competition, with a more pronounced effect noted
with MSM+vitamin C treatment. Moreover, in a recently
published human study [10], MSM supplementation at
50 mg/kg was provided to untrained healthy men for
10 days prior to performing a 14 km run. Blood was col-
lected before and at times through 48 hours of exercise
recovery and analyzed for lipid, protein, and glutathione
oxidation. As expected, acute exercise resulted in an in-
crease in oxidative stress; however, this increase was
blunted significantly with MSM supplementation ascompared to placebo. Collectively, the results of Mara-
ñon et al. [11] and Nakhostin-Roohi et al. [10] provide
initial evidence that prophylactic intake of MSM prior to
exercise may alleviate the oxidative stress that is often
observed following strenuous bouts of exercise, in par-
ticular in those who are not accustomed to the stress of
exercise [20]. Although ROS have been linked to poten-
tial problems in muscle integrity and the generation of
muscle force [21], the above studies did not include any
measure of physical performance in the design. This is
certainly a limitation and such measures should be con-
sidered in future studies investigating the impact of
MSM on exercise recovery.
Aside from measures of antioxidant status (TEAC and
glutathione), we included the measure of homocysteine
in the current design. Homocysteine is a non-protein
amino acid, with elevated levels in circulation thought to
be associated with an increased risk of cardiovascular
disease; although recent evidence questions this associ-
ation [22]. A study by Kim et al. reported a statistically
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in a sample of knee osteoarthritis patients following
intake of MSM at a dosage of 6 grams per day for
12 weeks [4]. Data from the present investigation
somewhat corroborate the work of Kim and colleagues,
as we noted a lowering of homocysteine during the
post-exercise period after subjects were supplemented
with MSM for four weeks (Figure 3). The mechanism
of action of this effect may be linked to methyl group
donation by MSM, in much the same way as done by
B-vitamins [23].
From a practical standpoint, we measured muscle per-
formance by calculating total work performed during
the final 3 sets of knee extension exercise. Despite some
positive findings for our non-exercise performance mea-
sures, we failed to note any difference in exercise per-
formance between pre and post intervention. In fact,
values were actually lower following MSM supplementa-
tion as compared to before supplementation. We have
no explanation for these findings other than recognizing
our small sample size and the potential for day-to-day
variance in knee extension “muscle endurance” perform-
ance, as has been noted for isokinetic testing [24]. Also
noteworthy, motivation is paramount when asking sub-
jects to perform repetitions to exhaustion.
In retrospect we believe that our chosen protocol may
not have been ideal to discern performance differences
between groups and across time. Although subjects per-
formed a total of 18 sets of knee extension exercise, the
first 15 sets were standardized in terms of repetition
number. Hence, subjects were only provided a total of 3
performance sets (16–18) to generate usable data for
performance comparison. Future work may include a
different exercise protocol, with the possible addition of
isometric and dynamic force, as well as power data as
done previously [25], in addition to actual volume load
(reps x load). This would provide for a more complete
assessment of muscle performance—as well as greater
potential for observed differences in muscle soreness
and oxidative stress related parameters. Moreover, the
“damaging” exercise protocol may be altered to include
a more robust model for inducing damage (e.g., pure ec-
centric loading using 1-RM values that are far greater
than those used in the present design) [16].
In addition to performance, we used two distinct ques-
tionnaires to determine the extent of either muscle sore-
ness or fatigue, before and following exercise, both pre
and post intervention. Although preliminary, MSM did
provide some evidence of effect at attenuating both
muscle soreness and fatigue (Figures 1 and 2, respect-
ively). As with other measures, additional larger scale
studies are needed to corroborate these findings. If future
work agrees with these initial findings, MSM may serve a
useful purpose in enhancing post-exercise recovery.Conclusion
Our data indicate that supplementation with MSM, spe-
cifically at a daily dosage of 3.0 grams, may favorably in-
fluence selected markers of exercise recovery. In
particular, to our knowledge, this was the first study to
observe an effect of MSM on antioxidant capacity, as
measured by blood TEAC. While this study was small in
scope, it is suggested that more research be done to ex-
tend these findings. Specifically, future studies should in-
clude a larger sample size, a placebo group for
comparison, the inclusion of additional markers of re-
covery and exercise performance (e.g., force and power),
as well as the consideration for a more strenuous
“muscle damaging” protocol and a longer time course of
post-exercise assessment (e.g., 4–7 days). Such work
may help to more fully elucidate the role of MSM in ex-
ercise recovery.
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